
## TODAY'S GRADE: B
A generally positive trading day with strong tech and chip sector performances offsetting some sector-specific weakness and geopolitical concerns.
## HOW INDEXES TRADED
**SPY:** +0.3% - trending higher with moderate strength
**QQQ:** +0.7% - led by tech and semiconductor gains, showing bullish momentum
**IWM:** +0.1% - choppy, small-cap lagging amid mixed sector performance
## BIGGEST MOVERS
### Winners
**$SKHYX** +14% - Blockbuster U.S. Nasdaq debut with $26.5 billion ADR offering fueling AI chip optimism
**$META** +3.5% - Bill Ackman’s large position rebounds strongly on renewed AI optimism and data center expansion plans
**$WDFC** +15% - WD-40 beats Q3 earnings expectations, driving a sharp rally
### Losers
**$DAL** -2.5% - Despite record revenue and profit beat, rising fuel costs weighed on sentiment
**$RIVN** -3% - Shares fell despite raised guidance, reflecting investor caution on valuation and competition
**$PFE** -1.2% - Price target cut by BofA Securities despite FDA approval of new bladder cancer label
## WHAT WORKED
Patterns or setups that worked today:
- **IPO Debut Momentum:** SK Hynix’s strong debut and follow-through buying in related leveraged ETFs demonstrated the power of marquee IPOs in driving sector rallies.
- **Earnings Beat Breakouts:** WD-40’s 15% jump post-earnings showed that solid margin beats can trigger sharp momentum runs.
- **AI-Related Tech Strength:** Meta’s rebound and chip stocks like SK Hynix and Broadcom benefited from renewed AI spending enthusiasm, confirming the sector’s leadership role.
## WHAT FAILED
Setups that didn't work:
- **Airline Earnings Fade:** Delta’s profit beat was not enough to overcome concerns about fuel costs, leading to a pullback, showing that cost pressures remain a key risk for the sector.
- **Guidance-Driven Selloffs:** Rivian’s raised guidance failed to sustain the stock, indicating investor skepticism on valuation and competitive pressures in EV space.
- **Pharma Downgrades:** Pfizer’s neutral rating and price target cut despite FDA label expansion highlighted that regulatory wins alone may not be enough to drive share gains.
## AFTER-HOURS WATCH
Earnings or news to monitor tonight:
- **$JPM** - Upcoming Q2 earnings on July 14 will be key to gauge financial sector momentum amid mixed economic signals.
- **$MSFT** - As a tech bellwether, its earnings will be critical to confirm ongoing AI-driven growth narratives.
- **$TSLA** - Watch for updates on Grok AI integration and any commentary on robotaxi regulatory risks, which could impact near-term sentiment.
## TOMORROW PREVIEW
**Early Watch:** **$JPM**, **$MSFT**, **$TSLA** setting up for earnings reactions; chip stocks to follow SK Hynix’s lead.
**Catalyst:** Key Q2 earnings from major banks and tech giants; geopolitical tensions and inflation data could add volatility.
**Bias:** Mildly bullish into tomorrow, supported by strong tech and chip sector momentum but tempered by macro and geopolitical uncertainties.
Replies (0)
No replies yet. Be the first to reply!
Please login to reply to this post.